drugset / Trial / NCT01700166
Umbilical Cord Blood in the Treatment of Stroke in Children.
Phase 1
Withdrawn
Aryn Knight
Baylor College of Medicine · collabCord Blood Registry, Inc. · collabM.D. Anderson Cancer Center - Houston · collabThe Institute for Rehabilitaion and Research Foundation · collabThe University of Texas Health Science Center, Houston · collab
NaSingle-groupOpen-labelTreatment
Summary
The specific aims of this study are: 1. To determine if Human Umbilical Cord Blood (hUCB) infusion is safe in children with perinatal arterial ischemic stroke (AIS). 2. To determine if late functional outcome, physiologic response, and anatomic findings are changed following hUCB infusion in children with perinatal AIS.
Timeline
- Start
- 2012-09
- Primary completion
- 2013-08
- Completion
- 2016-12
Outcome
Outcome not reported
Stopped: “Principal Investigator relocated; Study may resume in Fl Hosp. for Children, Orlando FL”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Human Cord Blood derived Stem Cell | Cell therapy | — | Intravenous |